VA Medical Center and UC College of Medicine Create General Clinical Research Center
The Department of Veterans Affairs (VA) Medical Center, Cincinnati, and the University of Cincinnati (UC) College of Medicine have established a site to study adults with complex medical or psychiatric disorders. The new site, named the General Clinical Research Center (GCRC), will accommodate studies from a variety of sponsors including the National Institutes of Health (NIH) and the VA Research Programs. A ribbon cutting ceremony will be held on April 15 at 1:00 p.m. in the GCRC located on the 4th floor of the Cincinnati VA. This ceremony is open to the public.
The GCRC offers a wide range of support to researchers including assistance with grant preparation and submission, Institutional Review Board and VA Research and Development Committee submission and processing, grant budgets and contracts, study assessments, and study logistics.
The GCRC space is made up of two monitored rooms for inpatients, five outpatient examination rooms, an investigational pharmacy, a phlebotomy room, and a fully equipped cardiac physiology laboratory.
Stephen M. Strakowski, MD, professor in the UC Department of Psychiatry, was appointed by the Cincinnati VA as the director of the GCRC. VA Associate Directors of the GCRC are Dave D'Alessio, MD, associate professor in the UC Department of Internal Medicine/Division of Endocrinology; and Paul E. Keck, MD, professor in the UC Department of Psychiatry.
For more information contact the GCRC Administrator Amelia T. Nasrallah by phone at (513) 558-2226 or (513) 861-3100, ext. 4486, or e-mail
.
Related Stories
Study: Additional radiation for liver cancer does not increase toxicity
March 10, 2026
New research led by University of Cincinnati Cancer Center researchers published in the American Journal of Clinical Oncology found external beam radiation therapy (EBRT) is safe to administer to patients with liver cancer even after they undergo a targeted internal radiation therapy called Y90.
Phase 1 trial tests probiotic treatment for radiation side effects in the gut
March 9, 2026
The University of Cincinnati Cancer Center’s Bailey Nelson, MD, has been awarded a $50,000 pilot grant from the Cancer Center to open a Phase 1 trial testing if a probiotic supplement can reduce gastrointestinal symptoms for patients undergoing whole pelvis radiotherapy.
Is uACR the key to cardiovascular and kidney disease prevention?
March 8, 2026
As a precision biomarker, the urinary albumin-to-creatinine ratio (uACR) can guide physicians toward personalized, patient-centered prevention and treatment of both cardiovascular disease (CVD) and chronic kidney disease (CKD), according to new data published in the Journal of Internal Medicine.